🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Nerve-SPARing Robotic Prostatectomy: The Impact of Patient Baseline Profiles on Erectile Function

Recruitingn/aAges 18 Years - 75 YearsMaleUniversity of Florence
NCT07747272 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

1. STUDY PURPOSE: Robot-assisted surgery for prostate cancer aims to remove the tumor while preserving the delicate nerves that control erections (called "nerve-sparing" surgery). Even with advanced robotics, some patients still experience erectile dysfunction after surgery. Recovery depends not only on the surgeon's technique (one-sided or two-sided nerve sparing), but also on patient unique baseline health profile. The present study aims to analyze how patient age, health history (like diabetes or high blood pressure), and pre-surgery sexual function affect recovery. Doctors will use this data to create a personalized prediction tool (a nomogram) to better advise future patients. 2. STUDY DESIGN: This study will not change, delay, or interfere with participants' standard medical care. The surgeon will choose the safest surgical path to treat cancer. To ensure the highest qualit

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age ≥ 18 and ≤ 75 years at the time of screening. 2. Histologically confirmed, clinically localized prostate cancer (cT1-cT2, Nx/0, Mx/0). 3. Candidates for robot-assisted radical prostatectomy (RARP) with a planned nerve-sparing approach (unilateral or bilateral) as determined by the attending urologist. 4. Patient is willing and able to complete validated quality-of-life questionnaires at baseline and during follow-up. 5. Signed informed consent prior to enrollment. Exclusion Criteria: 1. Pre-existing severe erectile dysfunction (baseline IIEF-5 score less than or equal to 7) unrelated to prostate cancer. 2. History of prior pelvic radiation, cryotherapy, or extensive pelvic surgery that disrupts neurovascular anatomy. 3. Neo-adjuvant androgen deprivation therapy (ADT) or chemotherapy. 4. Severe psychiatric or cognitive illness preventing reliable self-reporting.
💊

What it tests

  • Not listed
📍

Where

1 site
AOU Careggi
Florence, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy